Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Lower strength Kaletra and Aluvia receive positive EMEA opinions

Jan. 29, 2008

Progenics initiates phase II PRO-140 trial for HIV

Jan. 25, 2008

FDA grants Intelence accelerated approval for HIV combination therapy

Jan. 21, 2008

Ardea's lead NNRTI for HIV to enter phase IIa proof-of-concept trial

Jan. 9, 2008

Anti-HIV drug apricitabine enters phase III

Jan. 4, 2008

New HIV aspartyl protease inhibitors disclosed in recent Tibotec patent

Jan. 3, 2008

Medivir and Presidio amend MIV-310 license agreement

Dec. 31, 2007

E.U. Commission approves first-in-class integrase inhibitor Isentress for HIV therapy

Dec. 27, 2007

Researchers find that component in male semen enhances HIV infection

Dec. 27, 2007

Advances in HIV treatment disclosed in recent patents

Dec. 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...